American Capital Advisory, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2018007
KETCHUM, ID
Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,107
+$453 QoQ
Shares Held
7
+40.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#733
of 780 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $90,620 across 24 Biotechnology names. ALNY ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
524 | $29,380 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
1,954 | $13,521 | |
| 3 | TECH |
BIO-TECHNE Corp
|
155 | $10,950 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
1,227 | $10,742 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16 | $7,947 | |
| 6 | ARGX |
Argenx SE
|
3 | $2,783 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4 | $2,494 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7 | $2,107 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,107 | 7 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,654 | 5 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,590 | 4 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,824 | 4 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,304 | 4 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||